Physician profile
Cristian Silva
NPI 1902426620
$1,875.17
in general payments reported to CMS, 2019-2025
20 companies · $232 in 2025
The $232 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $325 · 2022: $983 · 2023: $291 · 2024: $43.99 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $566.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $506.83 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $347.17 | 2021-2023 | Jardiance |
| Boston Scientific Corporation | $212.61 | 2022-2025 | Watchman Flx, Watchman Access System |
| Pfizer INC. | $189.69 | 2021-2024 | |
| Esperion Therapeutics, INC. | $143.11 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $59.90 | 2021-2023 | Lifevest |
| Otsuka America Pharmaceutical, INC. | $49.00 | 2022-2023 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $46.60 | 2021-2023 | Brilinta |
| Novo Nordisk INC | $44.25 | 2022-2023 | Rybelsus, Ozempic |
| Kiniksa Pharmaceuticals, LTD. | $39.54 | 2022-2023 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $33.84 | 2025 | |
| Medicomp INC | $29.70 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $26.52 | 2022 | |
| Abbott Laboratories | $26.47 | 2025 | Cardiomems |
| Biotronik INC. | $24.38 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $21.81 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.00 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $18.86 | 2021 | |
| Medtronic, INC. | $18.54 | 2022 | |
| Gilead Sciences, INC. | $16.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cristian Silva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.